News
We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
Clinical Outcomes will be presenting at this year’s International Society for Quality of Life Research (ISOQOL) conference!
Oxford University Innovation's Clinical Outcome team will be attending and presenting at the annual ISOQOL 2023 conference in Calgary, Canada from the 18th - 21st October 2023.
Mapping the Future for Clinical Outcomes at OUI
Dr Liisa Chisty joins Oxford University Innovation's Clinical Outcomes Team, reinforcing their commitment to patient-centric care and licensing Clinical Outcome Assessments (COAs).
Clinical Outcomes are proud to be co-sponsoring the 7th UK PROMs Research Conference on the 22nd June!
Less than two weeks to go! The 7th UK Patient Reported Outcome Measures (PROMs) Research Conference, hosted by our colleagues at the School of Health and Related Research, University of Sheffield, will be taking place Thursday 22nd June 2023.
Measuring routine activities, social engagement and emotional well-being among the elderly
Evaluating response rates, data quality, score reliability and scaling assumptions of the Oxford Participation and Activities Questionnaire (Ox-PAQ) within Sweden.
Connect with us at the 12th International Congress of Arthroplasty Registries – May 13-15th, 2023
The Clinical Outcomes team are proud to announce their participation in the 12th International Congress of Arthroplasty Registries.
How are you measuring the healthcare and societal impacts of your patient’s health conditions?
The PECUNIA Resource Use Measurement (PECUNIA RUM) instrument is now available to licence through Oxford University Innovation’s Clinical Outcomes team.
Call for Abstracts – the 7th National Patient Reported Outcome Measures (PROMs) Research Conference ‘PROMs Across the Lifespan’
The 7th National Patient Reported Outcome Measures (PROMs) Research Conference 'Call for Abstracts' closes 11:59pm on Tuesday 7th February 2023.
The Giant Cell Arteritis Patient Reported Outcome Measure (GCA-PRO) is now available to licence
The GCA-PRO is a validated outcome measure for use in clinical trials, observation studies and clinical practice. It can also be used as a communication tool between patients and their clinicians, to highlight areas of greatest importance to patients, within face to face or online consultations.
Validation of OBERD’s computerised adaptive testing for the Oxford Hip, Knee, Shoulder, and Elbow scores
Researchers Conrad Harrison, Jeremy Rodrigues and OBERD worked together to validate OBERD CAT’s accuracy of the Oxford Hip, Knee, Shoulder, Elbow Scores and their subscales!